Corporate Profile

Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias. Robotic Magnetic Navigation helps physicians provide unsurpassed patient care with improved safety and unmatched catheter precision, reach, and stability. Over 100,000 patients have been treated with Stereotaxis technology at over 100 leading global hospitals.

Investors

Date	Title
11/10/26	Stereotaxis Reports 2026 Third Quarter Financial Results & Business Updates
11/10/26	Stereotaxis Announces Convertible Note Financing of Up To $24 Million
11/02/26	First-in-Human Coronary Intervention Study Results of Robocath’s Next-Generation Robotic System Highlighted at TCT
10/30/26	Canon Medical and Stereotaxis Collaborate to Advance Robotic Electrophysiology

Recent Filings

Filing date	Description	Form
11/12/26	Statement of changes in beneficial ownership of securities	4
11/12/26	Statement of changes in beneficial ownership of securities	4
11/12/26	SCHEDULE 13D/A - Description	SCHEDULE 13D/A
11/10/26	Report of unscheduled material events or corporate event	8-K

Alert type
Stereotaxis Inc. SEC Filing
Stereotaxis Inc. Press Release Alert

Investors

Corporate Profile

Investors

View All (Press Releases)

View All (Events)

Recent Filings

View All (Recent Fillings)